Autocrine transforming growth factor α regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells

Rajinder S. Sawhney, Michelle M. Cookson, Bhavya Sharma, Jennie Hauser, Michael G. Brattain

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recently, we showed that autocrine transforming growth factor α (TGFα) controls the epidermal growth factor receptor (EGFR)-mediated basal expression of integrin α2, cell adhesion and motility in highly progressed HCT116 colon cancer cells. We also reported that the expression of basal integrin α2 and its biological effects are critically controlled by the constitutive activation of the ERK/MAPK pathway (Sawhney, R. S., Sharma, B., Humphrey, L. E., and Brattain, M. G. (2003) J. Biol. Chem. 278, 19861-19869). In the present report, we further examine the downstream signaling mechanisms underlying EGFR/ ERK signaling and integrin α2 function in HCT116 cells. Selective MEK inhibitors attenuated TGFα-mediated basal activation of p70S6K (S6K) specifically at Thr-389, indicating that this S6K site is downstream of ERK/MAPK signaling. Cells were treated with the selective protein kinase C (PKC) inhibitor bisindolylmaleimide to determine the role of PKC in S6K activation. The Thr-421 and Ser-424 phosphorylation sites of S6K were specifically inhibited by bisindolylmaleimide, which also blocked integrin α2 expression, cell adhesion, and motility. These data establish a novel cell motility function of S6K via PKC activation in a cancer cell. In addition, we examined whether mammalian target of rapamycin signaling controls S6K activation. Rapamycin inhibited constitutive S6K phosphorylation specifically at Thr-389, Thr-421, and Ser-424 sites. The assignment of these phosphorylation sites on S6K to biological functions was unequivocally confirmed by transfection of cells with specific single phosphorylation site dominant negative mutants. These experiments show for the first time that autocrine TGFa regulates cell adhesion function by multiple signaling pathways via specific phosphorylation sites of S6K in cancer cells.

Original languageEnglish (US)
Pages (from-to)47379-47390
Number of pages12
JournalJournal of Biological Chemistry
Volume279
Issue number45
DOIs
StatePublished - Nov 5 2004

Fingerprint

Phosphorylation
Cell adhesion
Transforming Growth Factors
Cell Adhesion
Colonic Neoplasms
Phosphotransferases
Integrins
Chemical activation
Cells
Protein Kinase C
Cell Movement
Sirolimus
Epidermal Growth Factor Receptor
70-kDa Ribosomal Protein S6 Kinases
HCT116 Cells
MAP Kinase Signaling System
Protein C Inhibitor
Mitogen-Activated Protein Kinase Kinases
Protein Kinase Inhibitors
Transfection

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Autocrine transforming growth factor α regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. / Sawhney, Rajinder S.; Cookson, Michelle M.; Sharma, Bhavya; Hauser, Jennie; Brattain, Michael G.

In: Journal of Biological Chemistry, Vol. 279, No. 45, 05.11.2004, p. 47379-47390.

Research output: Contribution to journalArticle

Sawhney, Rajinder S. ; Cookson, Michelle M. ; Sharma, Bhavya ; Hauser, Jennie ; Brattain, Michael G. / Autocrine transforming growth factor α regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 45. pp. 47379-47390.
@article{9f54c29f36e046508d1ef4766ccb956c,
title = "Autocrine transforming growth factor α regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells",
abstract = "Recently, we showed that autocrine transforming growth factor α (TGFα) controls the epidermal growth factor receptor (EGFR)-mediated basal expression of integrin α2, cell adhesion and motility in highly progressed HCT116 colon cancer cells. We also reported that the expression of basal integrin α2 and its biological effects are critically controlled by the constitutive activation of the ERK/MAPK pathway (Sawhney, R. S., Sharma, B., Humphrey, L. E., and Brattain, M. G. (2003) J. Biol. Chem. 278, 19861-19869). In the present report, we further examine the downstream signaling mechanisms underlying EGFR/ ERK signaling and integrin α2 function in HCT116 cells. Selective MEK inhibitors attenuated TGFα-mediated basal activation of p70S6K (S6K) specifically at Thr-389, indicating that this S6K site is downstream of ERK/MAPK signaling. Cells were treated with the selective protein kinase C (PKC) inhibitor bisindolylmaleimide to determine the role of PKC in S6K activation. The Thr-421 and Ser-424 phosphorylation sites of S6K were specifically inhibited by bisindolylmaleimide, which also blocked integrin α2 expression, cell adhesion, and motility. These data establish a novel cell motility function of S6K via PKC activation in a cancer cell. In addition, we examined whether mammalian target of rapamycin signaling controls S6K activation. Rapamycin inhibited constitutive S6K phosphorylation specifically at Thr-389, Thr-421, and Ser-424 sites. The assignment of these phosphorylation sites on S6K to biological functions was unequivocally confirmed by transfection of cells with specific single phosphorylation site dominant negative mutants. These experiments show for the first time that autocrine TGFa regulates cell adhesion function by multiple signaling pathways via specific phosphorylation sites of S6K in cancer cells.",
author = "Sawhney, {Rajinder S.} and Cookson, {Michelle M.} and Bhavya Sharma and Jennie Hauser and Brattain, {Michael G.}",
year = "2004",
month = "11",
day = "5",
doi = "10.1074/jbc.M402031200",
language = "English (US)",
volume = "279",
pages = "47379--47390",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "45",

}

TY - JOUR

T1 - Autocrine transforming growth factor α regulates cell adhesion by multiple signaling via specific phosphorylation sites of p70S6 kinase in colon cancer cells

AU - Sawhney, Rajinder S.

AU - Cookson, Michelle M.

AU - Sharma, Bhavya

AU - Hauser, Jennie

AU - Brattain, Michael G.

PY - 2004/11/5

Y1 - 2004/11/5

N2 - Recently, we showed that autocrine transforming growth factor α (TGFα) controls the epidermal growth factor receptor (EGFR)-mediated basal expression of integrin α2, cell adhesion and motility in highly progressed HCT116 colon cancer cells. We also reported that the expression of basal integrin α2 and its biological effects are critically controlled by the constitutive activation of the ERK/MAPK pathway (Sawhney, R. S., Sharma, B., Humphrey, L. E., and Brattain, M. G. (2003) J. Biol. Chem. 278, 19861-19869). In the present report, we further examine the downstream signaling mechanisms underlying EGFR/ ERK signaling and integrin α2 function in HCT116 cells. Selective MEK inhibitors attenuated TGFα-mediated basal activation of p70S6K (S6K) specifically at Thr-389, indicating that this S6K site is downstream of ERK/MAPK signaling. Cells were treated with the selective protein kinase C (PKC) inhibitor bisindolylmaleimide to determine the role of PKC in S6K activation. The Thr-421 and Ser-424 phosphorylation sites of S6K were specifically inhibited by bisindolylmaleimide, which also blocked integrin α2 expression, cell adhesion, and motility. These data establish a novel cell motility function of S6K via PKC activation in a cancer cell. In addition, we examined whether mammalian target of rapamycin signaling controls S6K activation. Rapamycin inhibited constitutive S6K phosphorylation specifically at Thr-389, Thr-421, and Ser-424 sites. The assignment of these phosphorylation sites on S6K to biological functions was unequivocally confirmed by transfection of cells with specific single phosphorylation site dominant negative mutants. These experiments show for the first time that autocrine TGFa regulates cell adhesion function by multiple signaling pathways via specific phosphorylation sites of S6K in cancer cells.

AB - Recently, we showed that autocrine transforming growth factor α (TGFα) controls the epidermal growth factor receptor (EGFR)-mediated basal expression of integrin α2, cell adhesion and motility in highly progressed HCT116 colon cancer cells. We also reported that the expression of basal integrin α2 and its biological effects are critically controlled by the constitutive activation of the ERK/MAPK pathway (Sawhney, R. S., Sharma, B., Humphrey, L. E., and Brattain, M. G. (2003) J. Biol. Chem. 278, 19861-19869). In the present report, we further examine the downstream signaling mechanisms underlying EGFR/ ERK signaling and integrin α2 function in HCT116 cells. Selective MEK inhibitors attenuated TGFα-mediated basal activation of p70S6K (S6K) specifically at Thr-389, indicating that this S6K site is downstream of ERK/MAPK signaling. Cells were treated with the selective protein kinase C (PKC) inhibitor bisindolylmaleimide to determine the role of PKC in S6K activation. The Thr-421 and Ser-424 phosphorylation sites of S6K were specifically inhibited by bisindolylmaleimide, which also blocked integrin α2 expression, cell adhesion, and motility. These data establish a novel cell motility function of S6K via PKC activation in a cancer cell. In addition, we examined whether mammalian target of rapamycin signaling controls S6K activation. Rapamycin inhibited constitutive S6K phosphorylation specifically at Thr-389, Thr-421, and Ser-424 sites. The assignment of these phosphorylation sites on S6K to biological functions was unequivocally confirmed by transfection of cells with specific single phosphorylation site dominant negative mutants. These experiments show for the first time that autocrine TGFa regulates cell adhesion function by multiple signaling pathways via specific phosphorylation sites of S6K in cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=8744304971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8744304971&partnerID=8YFLogxK

U2 - 10.1074/jbc.M402031200

DO - 10.1074/jbc.M402031200

M3 - Article

C2 - 15304500

AN - SCOPUS:8744304971

VL - 279

SP - 47379

EP - 47390

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 45

ER -